WO1990000623A1 - Multi-label time-resolved fluorescence analysis of nucleic acid sequences using lanthanide chelates - Google Patents
Multi-label time-resolved fluorescence analysis of nucleic acid sequences using lanthanide chelates Download PDFInfo
- Publication number
- WO1990000623A1 WO1990000623A1 PCT/SE1989/000378 SE8900378W WO9000623A1 WO 1990000623 A1 WO1990000623 A1 WO 1990000623A1 SE 8900378 W SE8900378 W SE 8900378W WO 9000623 A1 WO9000623 A1 WO 9000623A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- different
- ligand
- excitation
- lanthanide
- label
- Prior art date
Links
- 229910052747 lanthanoid Inorganic materials 0.000 title claims abstract description 30
- 150000002602 lanthanoids Chemical class 0.000 title claims abstract description 30
- 150000007523 nucleic acids Chemical group 0.000 title claims abstract description 17
- 238000012921 fluorescence analysis Methods 0.000 title description 2
- 230000005284 excitation Effects 0.000 claims abstract description 36
- 239000003446 ligand Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000012634 fragment Substances 0.000 claims abstract description 11
- 238000012300 Sequence Analysis Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 65
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 40
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 20
- 238000005160 1H NMR spectroscopy Methods 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- -1 Argon ion Chemical class 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 14
- 229910052693 Europium Inorganic materials 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 229910052771 Terbium Inorganic materials 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000001962 electrophoresis Methods 0.000 description 12
- 238000012163 sequencing technique Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000007850 fluorescent dye Substances 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000013522 chelant Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000003818 flash chromatography Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- JDXOXNWUEHAYRU-UHFFFAOYSA-N bis[6-(hydroxymethyl)pyridin-2-yl]methanone Chemical compound OCC1=CC=CC(C(=O)C=2N=C(CO)C=CC=2)=N1 JDXOXNWUEHAYRU-UHFFFAOYSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- KQMXEPUVRHXWKX-UHFFFAOYSA-N 2-(bromomethyl)-6-[6-(bromomethyl)pyridin-2-yl]-4-ethoxypyridine Chemical compound CCOC1=CC(CBr)=NC(C=2N=C(CBr)C=CC=2)=C1 KQMXEPUVRHXWKX-UHFFFAOYSA-N 0.000 description 5
- SZLQAUWIUGRPND-UHFFFAOYSA-N 2-bromo-6-(dimethoxymethyl)pyridine Chemical compound COC(OC)C1=CC=CC(Br)=N1 SZLQAUWIUGRPND-UHFFFAOYSA-N 0.000 description 5
- HISIFLSUVIYVCK-UHFFFAOYSA-N 2-methyl-6-(6-methylpyridin-2-yl)-4-nitro-1-oxidopyridin-1-ium Chemical compound CC1=CC=CC(C=2[N+](=C(C)C=C(C=2)[N+]([O-])=O)[O-])=N1 HISIFLSUVIYVCK-UHFFFAOYSA-N 0.000 description 5
- UNTAEVDODOLIOM-UHFFFAOYSA-N 4-ethoxy-2-methyl-6-(6-methylpyridin-2-yl)-1-oxidopyridin-1-ium Chemical compound CCOC1=CC(C)=[N+]([O-])C(C=2N=C(C)C=CC=2)=C1 UNTAEVDODOLIOM-UHFFFAOYSA-N 0.000 description 5
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- GZYHBVQCKKJDRO-UHFFFAOYSA-N bis[6-(dimethoxymethyl)pyridin-2-yl]methanone Chemical compound COC(OC)C1=CC=CC(C(=O)C=2N=C(C=CC=2)C(OC)OC)=N1 GZYHBVQCKKJDRO-UHFFFAOYSA-N 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- COWRLPBJJIHRMX-UHFFFAOYSA-N 2-methyl-6-(6-methylpyridin-2-yl)-1-oxidopyridin-1-ium Chemical compound CC1=CC=CC(C=2[N+](=C(C)C=CC=2)[O-])=N1 COWRLPBJJIHRMX-UHFFFAOYSA-N 0.000 description 4
- LFVCCQHULPCIBO-UHFFFAOYSA-N 4-ethoxy-2-methyl-6-(6-methylpyridin-2-yl)pyridine Chemical compound CCOC1=CC(C)=NC(C=2N=C(C)C=CC=2)=C1 LFVCCQHULPCIBO-UHFFFAOYSA-N 0.000 description 4
- RCADNTPGGQXRML-UHFFFAOYSA-N 6-(6-formylpyridine-2-carbonyl)pyridine-2-carbaldehyde Chemical compound O=CC1=CC=CC(C(=O)C=2N=C(C=O)C=CC=2)=N1 RCADNTPGGQXRML-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- JIDHGHSHRMFFLC-UHFFFAOYSA-N bis[6-(bromomethyl)pyridin-2-yl]methanone Chemical compound BrCC1=CC=CC(C(=O)C=2N=C(CBr)C=CC=2)=N1 JIDHGHSHRMFFLC-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229960004132 diethyl ether Drugs 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 238000000695 excitation spectrum Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000011527 multiparameter analysis Methods 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000012258 stirred mixture Substances 0.000 description 3
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OJVAMHKKJGICOG-UHFFFAOYSA-N 2,5-hexanedione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- CZEPJJXZASVXQF-ZETCQYMHSA-N ethyl (2s)-2,6-diaminohexanoate Chemical compound CCOC(=O)[C@@H](N)CCCCN CZEPJJXZASVXQF-ZETCQYMHSA-N 0.000 description 2
- LJDNMOCAQVXVKY-UHFFFAOYSA-N ethyl 2-[(2-ethoxy-2-oxoethyl)amino]acetate Chemical compound CCOC(=O)CNCC(=O)OCC LJDNMOCAQVXVKY-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000037230 mobility Effects 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- OHJPGUSXUGHOGE-UHFFFAOYSA-N 2-methyl-6-(6-methylpyridin-2-yl)pyridine Chemical compound CC1=CC=CC(C=2N=C(C)C=CC=2)=N1 OHJPGUSXUGHOGE-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
- QWFHFNGMCPMOCD-UHFFFAOYSA-N 6-bromopyridine-2-carbaldehyde Chemical compound BrC1=CC=CC(C=O)=N1 QWFHFNGMCPMOCD-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229910016644 EuCl3 Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- TVMUHOAONWHJBV-UHFFFAOYSA-N dehydroglycine Chemical compound OC(=O)C=N TVMUHOAONWHJBV-UHFFFAOYSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 125000006371 dihalo methyl group Chemical group 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- NNMXSTWQJRPBJZ-UHFFFAOYSA-K europium(iii) chloride Chemical compound Cl[Eu](Cl)Cl NNMXSTWQJRPBJZ-UHFFFAOYSA-K 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000005055 short column chromatography Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- GFISHBQNVWAVFU-UHFFFAOYSA-K terbium(iii) chloride Chemical compound Cl[Tb](Cl)Cl GFISHBQNVWAVFU-UHFFFAOYSA-K 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000001685 time-resolved fluorescence spectroscopy Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Definitions
- nucleic acid sequence analysis has a central role in molecular biology.
- the presently available techniques for nucleic acid sequence analysis are laborious and expensive and often involve the use of radioisotopes. For this reason, and for sequencing an endless number of genes including the human genome with 3 x 10 9 bases, the development of an automated non-isotopic method for nucleic acid sequence analysis is extremely important.
- the strategy of the present invention is to provide an automatic real time nucleic acid sequence analyser for a single column electrophoresis system using four fluorescent probes for a simultaneous read-out of each of the four base specific reactions.
- the nucleic acid fragments generated in each reaction are identified on the basis of the specific excitation and emission wavelengths of the fluorescent probes.
- the conventional fluorescent probes however, have strongly overlapping excitation and emission spectra as shown in the work of Smith et al. In order to overcome this problem it was decided to investigate the possibility of using fluorescent lanthanide chelates in automatic real time nucleic acid sequencing.
- Lanthanide chelates have become a very promising alternative as labeling or dye material for biospecific assays and cell analyses (Hemmila, I., 1985, Anal. Chem. 57: 1676-1681; Hemmila, I., Dakubu, S., Mukkala, V-M. , Siitari, H. and Lövgren, T. 1984, Anal. Biochem. 137: 335-343).
- Europium and terbium have emission bands at 614 nm and 545 nm, respectively, and they also provide relatively strong fluorescence when they form appropriate chelates.
- Samarinium has its specific emission band at 640 nm, which can be efficiently separated from the emission of Eu and Tb, and consequently the use of Eu, Tb and Sm allows a three parameter analysis in the same sample.
- the fluorescence emission of the other lanthanides is too weak or their chelates currently known are not stable in water solutions. Therefore, it is difficult to find for example four lanthanides with different emission wavelengths for multiparameter analysis using four labels in the same sample.
- This invention is related to the discovery of new chelate structures which include an active functional group for covalent binding to modified nucleic acid fragments and which almost equally bind europium and terbium but have different excitation wavelengths.
- ligand A has the excitation maximum at 274 nm and ligand B at 307 nm.
- the following combinations of four different lanthanide chelates are then useful for analysing the sample with four parameters.
- the band widths of the excitation and emission spectra of these chelates as shown in Figures 1-4 - are narrow enough for the detection of each of these four chelates in the same sample using a filter fluorometer. In actual practice, this is achieved by changing the excitation and emission wavelengths according to the above table, and recording four signals for each measurement.
- DNA sequencing the recording of each of the four DNA terminals (A, C, G and T) directly from the electrophoresis in the same column can be carried out using an appropriate double excitation/double emission wavelength fluorometer where recording of each wavelength combination is fast enough when compared with the movement of the DNA bands in the electrophoresis gel.
- the sensitivity is of importance in the detection of nucleic acid bands from electrophoresis.
- the most important sources of the background of biochemical and biological samples are the "autofluorescence" and the scattering.
- the light emitted from these sources appears simultaneously with or promptly after the excitation as the fluorescence decay time of bio-organic substances is very short.
- the use of lanthanide chelates as fluorescent probes offers a possibility for efficient reduction of the background and scattering because the fluorescence decay time of lanthanides is long.
- Time-resolved fluorometry efficiently discriminates the prompt background from the long decay fluorescence of the probe because measurement does not occur until a certain time has elapsed from the moment of excitation.
- it offers an almost ideal way of measuring probes with long fluorescence decay and considerably improves the sensitivity compared with the conventional measurement methods with short decay time organic fluorescent probes.
- Lanthanides and their chelates are a special group of compounds which display ion fluorescence with decay times in the order of 50 to 1000 ⁇ sec. and these compounds are very useful for time-resolved microsecond fluorometry.
- the lanthanide chelates can provide comparable, or better overall sensitivity when used in time-resolved fluorescence detection (Soini & Kojola, Clin. Chem. 29, 65, 1983). This is the case despite the lower quantum yield which is around one tenth or less that of the best organic fluorescent compounds. The low quantum yield stems largely from the wide Stokes shift and the long decay time of the fluorescent signal.
- a simple fluorometric system based on the use of a Xenon flash lamp as an excitation source and interference filters for selecting the proper excitation and emission bands.
- Small Xenon flash lamps with a pulse duration of 1 ⁇ s are commercially available and well suited for this purpose.
- the operation of the time-resolved fluorometric system is shown schematically in Fig. 6.
- the light source is pulsed having a width of t p .
- the signal has a maximum instantaneous intensity I p at the end of the excitation pulse.
- the excited states of the fluorescent label relax with a decay time ⁇ and after a suitable delay time t d the signal from the detector is sampled for a certain period of gate time, t 2 .
- the fluorescence signal will be integrated during the gate time t p over a definite number of measurement cycles (n).
- Instrumentation which is available and applicable to time-resolved fluorometric studies with lanthanide chelates should be equipped with a pulsed light source producing very short light pulses in comparison with the actual decay times.
- the interferences between different fluorescent complexes can be reduced by optimizing the delay time t d and gate time t g , because the complexes have different decay times ⁇ . Therefore, in addition to optimizing the excitation and emission bands in multiparameter analysis, it is important to control the t d and t g .
- the control should be made automatic and synchronous with the wavelength control.
- FIG. 7 illustrates the principle of the nucleic acid sequencing device according to the invention.
- the electrophoresis column (3) communicates with an upper buffer reservoir (1) and a lower buffer reservoir (2).
- the excitation light sources producing light pulses of wavelength 274 nm (5) and wavelength 307 nm (6) incorporate an appropriate interference filter and lens system.
- the light pulses are focused in point (4) in the column (3). Fluorescence emissions from the column are collected to the detectors (7) and (8).
- the detectors include an appropriate lens system and interference filters for wavelengths 544 nm and 614 nm.
- the excitation light sources and detectors are controlled by the electronics unit, and activated periodically for example as follows
- 4th cycle light source 6 detector 8 in such a way that emissions at both wavelengths are recorded for both excitation wavelengths and these 4 cycles are repeated until a sufficient number of photon counts has been recorded for acceptable statistical precision.
- the electronic control system is also adjusted to record the fluorescence emission in a time-resolved mode.
- ligands A and B and for terbium and europium are presented as examples.
- the invention is not limited to the use of terbium and europium as a pair, or ligand A (274 nm max excitation) and ligand B (307 nm max excitation) as a pair, but any other pairs with appropriate wavelengths are within the scope of this invention.
- 6,6'-Dimethyl-2,2'-bipyridine-N-oxide (1.50 g, 0.00749 moles) was dissolved in concentrated sulphuric acid (8.0 ml) and fuming nitric acid (6.0 ml) and the mixture was heated at 100oC for four hours. The solution was poured slowly into ice-water and the pH was adjusted to 5.5 with 10 % sodium hydroxide. The product was filtered and dried.
- 6-Bromo-2-pyridinecarboxaldehyde J.Am.Chem.Soc. 91, (11), 3500 (1970)
- J.Am.Chem.Soc. 91, (11), 3500 (1970) (11.38 g, 62.2 mmoles) was dissolved in a mixture of dry methanol (200 ml) and trimethyl orthoformate (26.5 g, 250 mmoles).
- p-toluenesulfonic acid monohydrate 250 mg
- the mixture was refluxed for 1 h, cooled and neutralized by addition of pyridine (5 ml). Evaporation of solvent and distillation of the product under reduced pressure yielded the pure dimethylacetal as a colorless liquid.
- 6-Bromo-2-dimethoxymethyl pyridine (14) (14.2 g, 61 mmoles) was dissolved in dry diethyl ether (200 ml) and cooled down to -70oC in a round bottom three-necke flask equipped with reflux condenser and dropping funnel while a gentle flow o dry argon was passing through the magnetically stirred mixture.
- Butyllithium (25.1 ml (2.6M), 65.3 mmoles) was added dropwise and the tempera ture of the reaction mixture was kept below -60oC.
- the mixture was stirred fo an additional 1 h after accomplised addition, and ethyl chloroformate (4.52 g 41.7 mmoles) dissolved in dry diethyl ether was introduced at such a rate tha the temperature did not exceed -60 C.
- the yellow suspension was stirred for 4 min at -60oC and then additionally for 15 min at -40oC.
- the ether phase wa separated and the aqueous phase was extracted twice with 100 ml of dichloromethane.
- the combined organic phase was evaporated and coevaporated with toluene which yielded crude title compound (15).
- This compound was synthesized following the general procedure for tetraester synthesis from Example 14b using compound (6) and diethyl iminodiacetate as starting materials.
- This compound was synthesized using the general procedure for nitrogroup reduction from Example 14c having compound (8) as a starting material.
- the monobromomethyl diester (19) was synthesized starting from compound (18) and one molecular equivalent of iminodiacetic acid diethyl ester, in a reaction analogous to that of Example 14 a. Yield: 62 %.
- 1 H NMR (60 MHz, CDCl 3 ) 1.21 (t, 6 H), 3.60 (s, 4 H), 4.08 (s, 2 H), 4.15 (q, 4 H), 4.58 (s, 2 H), 7.22-8.15 (m, 6 H) .
- the hexadecamer oligonucleotide of M 13 phage sequencing primer was synthesized using Pharmacia Gen Assembler solid phase nucleic acid synthesizer (Pharmacia, Sweden) following the recommended conditions. When the oligonucleotide synthesis had been accomplished the detritylated compound was subjected to the reaction with 1,1'-carbonyldiimidazole and diaminohexane according to Nucleic Acids Research 14,, 7987-7994 (1986).
- the reactions were monitored by FPLC, and labeled products from each reaction were separated in ion-pair mode using the reverse phase FPLC system.
- the purified sequences were characterized by their fluorescent spectra which were found to be identical to the unbound labels.
- the four differently labeled primers did not show any differences in their electrophoretic mobilities when run under the real sequencing conditions on a 20 % acrylamide gel. This reflects the fact that all labels employed are indeed very closely structure related. No differences were found even when electrophoresis was used for running free labels.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention pertains to a method for simultaneous real time fluorometric sequence analysis of nucleic acid fragments of different lengths and four different terminals, the fragments being labelled with different fluorescent labels for the respective terminating bases. The fragments are labelled with four different labels comprising the same two lanthanides and the same two ligands as follows: label 1 = ligand 1 + lanthanide 1, label 2 = ligand 2 + lanthanide 1, label 3 = ligand 1 + lanthanide 2, label 4 = ligand 2 + lanthanide 2, where ligands 1 and 2 have different excitation wavelengths and lanthanides 1 and 2 have different emission wavelengths, excitation light is generated in the form of light pulses alternating between the different excitation wavelengths of the ligands, and the photons emitted by the labels are detected periodically for the different emission wavelengths of the lanthanides.
Description
Multi-label time-resolved fluorescence analysis of nucleic acid sequences using lanthanide chelates
The structural analysis of nucleic acid has a central role in molecular biology. The presently available techniques for nucleic acid sequence analysis are laborious and expensive and often involve the use of radioisotopes. For this reason, and for sequencing an endless number of genes including the human genome with 3 x 109 bases, the development of an automated non-isotopic method for nucleic acid sequence analysis is extremely important.
The commonly used sequencing methods are based on the work by Sanger et al. (Sanger, F. , Nicklen, S. & Coulson, A.R., 1977, Proc. Natl. Acad. Sci. USA, 74: 5463-5467). Using an enzymatic method DNA fragments terminating in either adenosine (A), cytidine (C), guanosine (G) or thymidine (T) can be produced. Another method of importance was developed by Maxam et al. (Maxam, A.M. and Gilbert, W. , 1980, Meth. Enzym. 65: 499-559). In this chemical method fragments terminating in G, G + A, C + T and C are produced. In both cases these four sets of DNA fragments with different lengths are then separated by electrophoresis in adjacent lanes in a high resolution polyacrylamide gel. The image of the gel can then be examined by a traditional autoradiographic technique.
Obviously a more cost effective method for automatic real time reading of electrophoresis scans is fluorescence labeling and the use of an appropriate fluorometric system for each electrophoresis lane. Conventional fluorescent probes including fluorescein or tetramethylrhodamine are applicable. This method, however, requires four independent excitation and detection systems and is clumsy and expensive. The use of Argon ion laser with beam splitters for the excitation is advantageous and improves the sensitivity. Recently Smith et al. (Smith L.M., Sanders, J.Z., Kaiser, R.J., Hughes, P., Dodd, C. , Connell, C.R., Heiner, C., Kent, S.B.H. & Hood, L.E. 1986, Nature, 321: 674-679) presented an automatic sequence reader device. This system was based on the use of four organic fluo
rescent probes (fluorescein, NBD, tetramethylrhodamine and Texas red) one for each terminal (A, C, G and T) and the labeled DNA fragments were electrophoresed in the same column. An Argon ion laser fluorescence detector was used for real time monitoring of the DNA bands during the electrophoresis. Fluorescence signals of each color indicated the DNA bands and the information was directly stored in the computer.
In the system described by Smith et al. (1986) the advantage of the method resided in the possibility to use a single column electrophoresis system, but the use of four traditional fluorescent probes with strongly overlapping excitation and emission spectra required Argon ion laser excitation and advanced, computer data reduction in order to eliminate signals caused by the interference of other fluorescent probes. The laser excitation was useful also for reducing the background scatter originating from the gel and from the associated circular glass tubing. The employment of Argon ion laser increases the system cost considerably.
The strategy of the present invention is to provide an automatic real time nucleic acid sequence analyser for a single column electrophoresis system using four fluorescent probes for a simultaneous read-out of each of the four base specific reactions. The nucleic acid fragments generated in each reaction are identified on the basis of the specific excitation and emission wavelengths of the fluorescent probes. The conventional fluorescent probes, however, have strongly overlapping excitation and emission spectra as shown in the work of Smith et al. In order to overcome this problem it was decided to investigate the possibility of using fluorescent lanthanide chelates in automatic real time nucleic acid sequencing.
Lanthanide chelates have become a very promising alternative as labeling or dye material for biospecific assays and cell analyses (Hemmila, I., 1985, Anal. Chem. 57: 1676-1681; Hemmila, I., Dakubu, S., Mukkala, V-M. , Siitari, H. and Lövgren, T. 1984, Anal. Biochem. 137: 335-343). A general problem in multi-parameter analysis, however, is the availability of a sufficient number of different lanthanides with different emission wavelength bands. Europium and terbium have emission bands at 614 nm and 545 nm, respectively, and they also provide relatively strong fluorescence when they form appropriate chelates. Samarinium has its specific emission
band at 640 nm, which can be efficiently separated from the emission of Eu and Tb, and consequently the use of Eu, Tb and Sm allows a three parameter analysis in the same sample. The fluorescence emission of the other lanthanides, however, is too weak or their chelates currently known are not stable in water solutions. Therefore, it is difficult to find for example four lanthanides with different emission wavelengths for multiparameter analysis using four labels in the same sample.
This invention is related to the discovery of new chelate structures which include an active functional group for covalent binding to modified nucleic acid fragments and which almost equally bind europium and terbium but have different excitation wavelengths. As an example, ligand A has the excitation maximum at 274 nm and ligand B at 307 nm. The following combinations of four different lanthanide chelates are then useful for analysing the sample with four parameters.
Chelate Excitation Emission
wavelength wavelength
Ligand A - Eu 274 nm 614 nm Compound 12
Ligand B - Eu 307 nm 614 nm Compound 24
Ligand A - Tb 274 nm 545 nm Compound 13
Ligand B - Tb 307 nm 545 nm Compound 25
The band widths of the excitation and emission spectra of these chelates as shown in Figures 1-4 - are narrow enough for the detection of each of these four chelates in the same sample using a filter fluorometer. In actual practice, this is achieved by changing the excitation and emission wavelengths according to the above table, and recording four signals for each measurement. In real time DNA sequencing the recording of each of the four DNA terminals (A, C, G and T) directly from the electrophoresis in the same column can be carried out using an appropriate double excitation/double emission wavelength fluorometer where recording of each wavelength combination is fast enough when compared with the movement of the DNA bands in the electrophoresis gel.
As demonstrated in Figure 1, the emission peaks of Tb and Eu at 544 nm and 614 nm, respectively, are sharp enough without any significant overlapping and interference for almost complete separation of the signals. In Figures 2 and 3 it can be seen that the excitation efficiencies of chelates with ligand A are very low at 307 nm. In Figures 4 and 5 it can be seen that the excitation efficiencies of chelates with ligand B at 274 nm are about 25 % of the maximum at 307 nm. This gives an interference which, however, is low enough for reliable data reduction.
Naturally, it is possible that some other ligands may provide even lower excitation efficiency at 274 nm or any other suitable wavelength, and consequently the interference between the signals is lower and no computer capacity is needed for interference reduction.
Besides the selectivity, the sensitivity is of importance in the detection of nucleic acid bands from electrophoresis. The most important sources of the background of biochemical and biological samples are the "autofluorescence" and the scattering. The light emitted from these sources appears simultaneously with or promptly after the excitation as the fluorescence decay time of bio-organic substances is very short. The use of lanthanide chelates as fluorescent probes offers a possibility for efficient reduction of the background and scattering because the fluorescence decay time of lanthanides is long. Time-resolved fluorometry efficiently discriminates the prompt background from the long decay fluorescence of the probe because measurement does not occur until a certain time has elapsed from the moment of excitation. Thus it offers an almost ideal way of measuring probes with long fluorescence decay and considerably improves the sensitivity compared with the conventional measurement methods with short decay time organic fluorescent probes.
Lanthanides and their chelates are a special group of compounds which display ion fluorescence with decay times in the order of 50 to 1000 μsec. and these compounds are very useful for time-resolved microsecond fluorometry. In comparison to the best organic fluorescent compounds the lanthanide chelates can provide comparable, or better overall sensitivity when used in time-resolved fluorescence detection (Soini & Kojola, Clin. Chem. 29, 65, 1983). This is the case despite the lower quantum yield which is around one tenth or less that of the best organic fluorescent compounds. The low quantum yield stems largely from the wide Stokes shift and the long decay time of the fluorescent signal.
High detection sensitivity can be achieved with a simple fluorometric system based on the use of a Xenon flash lamp as an excitation source and interference filters for selecting the proper excitation and emission bands. Small Xenon flash lamps with a pulse duration of 1 μs are commercially available and well suited for this purpose.
The operation of the time-resolved fluorometric system is shown schematically in Fig. 6. The light source is pulsed having a width of tp. The signal has a maximum instantaneous intensity Ip at the end of the excitation pulse. The excited states of the fluorescent label relax with a decay time τ and after a suitable delay time td the signal from the detector is sampled for a certain period of gate time, t2. The excitation is repeated at repetition frequency f and the time interval between the pulses tr = 1/f. The fluorescence signal will be integrated during the gate time tp over a definite number of measurement cycles (n).
Instrumentation which is available and applicable to time-resolved fluorometric studies with lanthanide chelates should be equipped with a pulsed light source producing very short light pulses in comparison with the actual decay times. The interferences between different fluorescent complexes can be reduced by optimizing the delay time td and gate time tg, because the complexes have different decay times τ. Therefore, in addition to optimizing the excitation and emission bands in multiparameter analysis, it is important to control the td and tg. The control should be made automatic and synchronous with the wavelength control.
Figure 7 illustrates the principle of the nucleic acid sequencing device according to the invention. The electrophoresis column (3) communicates with an upper buffer reservoir (1) and a lower buffer reservoir (2). The excitation light sources producing light pulses of wavelength 274 nm (5) and wavelength 307 nm (6) incorporate an appropriate interference filter and lens system. The light pulses are focused in point (4) in the column (3). Fluorescence emissions from the column are collected to the detectors (7) and (8). The detectors include an appropriate lens system and interference filters for wavelengths 544 nm and 614 nm.
The excitation light sources and detectors are controlled by the electronics unit, and activated periodically for example as follows
1st cycle light source 5 detector 7
2nd cycle light source 5 detector 8
3rd cycle light source 6 detector 7
4th cycle light source 6 detector 8 in such a way that emissions at both wavelengths are recorded for both excitation wavelengths and these 4 cycles are repeated until a sufficient
number of photon counts has been recorded for acceptable statistical precision. The electronic control system is also adjusted to record the fluorescence emission in a time-resolved mode.
Because the constructions of the flash light sources and detectors are relatively simple, the employment of two separate units for both wavelengths does not increase the cost of the system significantly. Naturally, single units with appropriate chopper systems for the Interference filters can also be used.
The wavelengths given above for ligands A and B and for terbium and europium are presented as examples. The invention is not limited to the use of terbium and europium as a pair, or ligand A (274 nm max excitation) and ligand B (307 nm max excitation) as a pair, but any other pairs with appropriate wavelengths are within the scope of this invention.
The invention is defined in the claims that form a part of the descriptive part of this specification. The invention will now be Illustrated by means of examples. The formulae and synthetic routes for the chelates employed are shown on scheme 1-3.
Example 1 (Scheme 1)
6,6'-Dimethyl-2,2'-bipyridine-N-oxide (1)
6,6'-Dimethyl-2,2'-bipyridine (1.97 g, 0.0107 moles) was dissolved in chloroform (10 ml). m-Chloroperbenzoic acid (1.85 g, 0.0107 moles) was dissolved in chloroform (40 ml), and added slowly to the bipyridine solution at 0-5ºC. After stirring for two hours at room temperature the solution was extracted twice with saturated sodium hydrogen carbonate solution and three times with water. The chloroform phase was dried and evaporated. The product was purified by flash chromatography.
Yield: 70 %
UV (in ethanol): 270 nm, 250 nm
1H NMR (400 MHz, CDCl3): 2.61 (s, 3 H) ; 2.62 (s, 3 H); 7.19 (d, 1 H, J = 8 Hz); 7.28 (d, 1 H, J = 5 Hz); 7.69 (t, 1 H, J = 8 Hz); 7.97 (t, 1 H, J = 5 Hz); 8.53 (d, 1 H, J = 8 Hz)
Example 2 (Scheme 1)
6,6'-Dimethyl-4-nitro-2,2 '-bipyridine-N-oxide (2)
6,6'-Dimethyl-2,2'-bipyridine-N-oxide (1.50 g, 0.00749 moles) was dissolved in concentrated sulphuric acid (8.0 ml) and fuming nitric acid (6.0 ml) and the mixture was heated at 100ºC for four hours. The solution was poured slowly into ice-water and the pH was adjusted to 5.5 with 10 % sodium hydroxide. The product was filtered and dried.
Yield: 53 %
m.p. 160-163ºC
UV (in ethanol): 337 nm, 294 nm, 233 nm
1H NMR (400 MHz, CDCl3): 2.62 (s, 3 H) ; 2.65 (s, 3 H); 7.27 (d, 1 H, J = 8 Hz);
7.75 (t, 1 H, J = 8 Hz); 8.10 (d, 1 H, J = 3 Hz); 8.56 (d, 1 H, J = 8 Hz);
8.93 (d, 1 H, J = 3 Hz)
Example 3 (Scheme 1)
6,6'-Dimethyl-4-ethoxy-2,2'-bipyridine-N-oxide (3)
6,6'-Dimethyl-4-nitro-2,2'-bipyridine-N-oxide (2) (1.0 g, 4.1 mmoles) was added
to sodium ethoxide solution made from (0.19 g, 0.0083 g-atoms) sodium and 25 ml ethanol. The mixture was stirred at 70ºC for 30 minutes. After neutralization with concentrated hydrochloric acid the reaction mixture was filtered and evaporated to dryness. The product was purified with flash chromatography
(silica, 0→50 % methanol/chloroform).
Yield: 90%
UV (in ethanol): 272 nm, 239 nm
1H NMR (400 MHz, CDCI3): 1.45 (t, 3 H, J = 7.0 Hz); 2.58 (s, 3 H); 2.61 (s, 3
H); 4.14 (q, 2 H, J = 7.0 Hz); 6.84 (d, 1 H, J = 3.4 Hz); 7.20 (d, 1 H, J =
7.7 Hz); 7.54 (d, 1 H, J = 3.4 Hz); 7.70 (t, 1 H, J = 7.7 Hz); 8.65 (d, 1 H, J
= 7.7 Hz)
Example 4 (Scheme 1)
6,6'-Dimethyl-4-ethoxy-2,2'-bipyridine (4)
6,6'-Dimethyl-4-ethoxy-2,2'-bipyridine-N-oxide (3) (0.96 g, 3.93 mmoles) was dissolved in chloroform (34 ml). After addition of phosphorus tribromide (3.0 ml) the mixture was refluxed for 1.5 hours. The solution was poured on ice, some chloroform was added and the phases were separated. The chloroform phase was extracted with water. The water phases were combined, made alkaline with sodium hydroxide solution, and extracted with chloroform. Evaporation of the organic phase followed by silica gel chromatography yielded the pure title product.
Yield: 69 %
UV (in ethanol): 286 nm, 243 nm
1H NMR (400 MHz, CDCl3): 1.45 (t, 3 H, J = 7.0 Hz); 2.56 (s, 3 H); 2.62 (s, 3 H); 4.18 (q, 2 H, J = 7.0 Hz); 6.67 (d, 1 H, J = 2.1 Hz); 7.14 (d, 1 H, J = 7.6 Hz); 7.67 (t, 1 H, J = 7.6 Hz); 7.75 (d, 1 H, J = 2.1 Hz); 8.16 (d, 1 H, J = 7.6 Hz).
Example 5
4-Ethoxy-6,6'-bis(bromomethyl)-2,2'-bipyridine (5)
Compound (4) (4,0 mmol) was dissolved in carbon tetrachloride (100 ml). N-bromo-succinimide (9.0 mmol) and a catalytic amount of dibenzoyl peroxide were added and the mixture was refluxed overnight. The mixture was filtered and the solution evaporated to dryness. The pure product was isolated after flash chromato
graphy separation.
Yield: 19 %
UV (in ethanol): 286 nm, 225 nm
1H NMR (400 MHz, CDCl3): 1.45 (t, J=7.0 Hz); 4.19 (q, J=7.0 Hz); 4.55 (s); 4.60
(s); 6.95 (d, J=2.3 Hz); 7.43 (dd, J=0.9 Hz & 7.6 Hz); 7.77 (t, J=7.6 Hz); 7.90
(d, J=2.3 Hz); 8.35 (dd, J=0.9 Hz & 7.6 Hz)
Example 6 (Scheme 2)
6-Bromo-2-dimethoxymethyl pyridine (14)
6-Bromo-2-pyridinecarboxaldehyde (J.Am.Chem.Soc. 91, (11), 3500 (1970)) (11.38 g, 62.2 mmoles) was dissolved in a mixture of dry methanol (200 ml) and trimethyl orthoformate (26.5 g, 250 mmoles). After addition of p-toluenesulfonic acid monohydrate (250 mg) the mixture was refluxed for 1 h, cooled and neutralized by addition of pyridine (5 ml). Evaporation of solvent and distillation of the product under reduced pressure yielded the pure dimethylacetal as a colorless liquid.
Yield: 96 %
1H NMR (60 MHz, CDCI3): 3.36 (s, 6 H); 5.25 (s, 1 H); 7.46 (m, 3 H)
Example 7 (Scheme 2)
Bis(6-dimethoxymethyl-2-pyridyl)ketone (15)
6-Bromo-2-dimethoxymethyl pyridine (14) (14.2 g, 61 mmoles) was dissolved in dry diethyl ether (200 ml) and cooled down to -70ºC in a round bottom three-necke flask equipped with reflux condenser and dropping funnel while a gentle flow o dry argon was passing through the magnetically stirred mixture.
Butyllithium (25.1 ml (2.6M), 65.3 mmoles) was added dropwise and the tempera ture of the reaction mixture was kept below -60ºC. The mixture was stirred fo an additional 1 h after accomplised addition, and ethyl chloroformate (4.52 g 41.7 mmoles) dissolved in dry diethyl ether was introduced at such a rate tha the temperature did not exceed -60 C. The yellow suspension was stirred for 4 min at -60ºC and then additionally for 15 min at -40ºC. The reaction wa quenched with methanol (20 ml) whereupon the reaction mixture was poured int saturated aqueous sodium hydrogen carbonate (300 ml). The ether phase wa
separated and the aqueous phase was extracted twice with 100 ml of dichloromethane. The combined organic phase was evaporated and coevaporated with toluene which yielded crude title compound (15).
1H NMR (60 MHz, CDCl3): 3.38 (s, 12 H); 5.30 (s, 2 H) ; 8.18-7.64 (m, 6 H)
Example 8 (Scheme 2)
Bis(6-formyl-2-pyridyl)ketone (16)
Crude bis(6-dimethoxymethyl-2-pyridyl)ketone (15) was dissolved in dioxane (40 ml) and water (25 ml). Concentrated hydrochloric acid (3 ml) was added and the magnetically stirred mixture was boiled for 15 min. The dark solution was then poured into saturated sodium hydrogen carbonate solution (100 ml) and extracted with chloroform (3×100 ml) . The residue after evaporation of the combined extracts was filtered through a short silica gel column using 4% EtOH/CHCl3 as a solvent and the fractions containing the product were evaporated. The product was crystallized from hot toluene (100 ml).
Yield: 65% (based on compound 14)
1H NMR (60 MHz, CDCI3): 8.48-8.11 (m, 6 H) ; 10.07 (s, 2 H)
Example 9 (Scheme 2)
Bis(6-hydroxymethyl-2-pyridyl)ketone (17)
To the compound (16) (2.5 g, 52.5 mmoles) in dry ethanol (50 ml) sodium borohydride (400 mg, 52.5 mmoles) dissolved in dry ethanol (30 ml) was added dropwise at 0ºC with gentle stirring. A satisfactory ratio of diol (17)/triol was obtained when about 2/3 of the borohydride had been added. Acetone (20 ml) was added for destroying unreacted reducing agent and the mixture was evaporated, dissolved in chloroform/ethanol 1:1 and extracted with saturated sodium hydrogen carbonate. The organic phase was evaporated, coevaporated with toluene and purified by silica gel column chromatography using EtOH/CHCl3 1:9 as an eluting solvent.
Yield: 48 %
1H NMR (60 MHz, CDCI3 + CD3OD): 4.77 (s, 4 H); 7.98-7.27 (m, 6 H)
Example 10 (Scheme 2)
Bis(6-bromomethyl-2-pyridyl)ketone (18)
Bis(6-hydroxymethyl-2-pyridyl)ketone (17) (410 mg, 1.68 mmoles), suspended in dichloromethane (15 ml) was stirred at room temperature in a 50 ml round bottom flask. Phosphorous tribromide (1.82 g, 6.72 mmoles) was added all at once and the mixture was refluxed for 5 min. The cooled mixture was partitioned between saturated sodium hydrogen carbonate and chloroform. The organic phase was collected, evaporated, coevaporated with toluene, and purified by flash chromatography using chloroform as solvent.
Yield: 87 %
UV (in dichloromethane): 282 nm
1H NMR (60 MHz, CDCl3); 4.55 (s, 4 H) ; 8.16-7.22 (m, 6 H)
Example 11 (Scheme 3)
L-Lysine ethyl ester (26)
Thionyl chloride (5.0 ml, 8.06 g, 68 mmoles) was dropped into 500 ml of icecooled dry ethanol. The stirred mixture was kept for 20 min at this temperature and L-lysine hydrochloride (20 g, 109 mmoles) was added.
The mixture was then refluxed for 3 h and concentrated to a volume of about 200 ml. 200 ml of diethylether was added and the crystallized product filtered off. Yield: 97 % dihydrochloride
Example 12 (Scheme 3)
ω-N-(4-Nitrobenzoyl)-L-lysine ethyl ester (27)
L-lysine HCl (5 g, 27.4 mmoles) dissolved in 50 ml of water was titrated wit 5 M NaOH to pH 10.5. 4-Nitrobenzoyl chloride (6.6 g, 36 mmoles) in dioxane (50 ml) and 5 M NaOH were slowly added keeping the vigorously stirred reaction mixture at pH 10.5.
After complete addition and disappearance of the pink color the reaction mixture was acidified with cone. HCl to pH 2 and extracted four times with dlethylether. The aqueous phase was concentrated to dryness, coevaporated twice with 200 ml of dry ethanol and suspended in 250 ml of dry ethanol previously treated with 10 ml of thionyl chloride. The mixture was refluxed for 3 h, filtered and evaporated. The residual material was partitioned between saturated sodium hydrogen carbonate and chloroform/ethanol 1:1 and the organic phase was dried over magnesium sulphate yielding a crude product which was purified by flash chromatography using 5% EtOH/chloroform as eluent.
Yield: 12 %
1H NMR (60 MHz, CDCI3): 8.25 (d, 2 H, J=9 Hz); 7.93 (d, 2 H, J=9 Hz); 6.87 (s, broad, 1 H); 4.17 (q, 2 H, J = 7 Hz); 3.30-3.60 (m, 3 H); 1.40-1.75 (m, 8 H); 1.24 (t, 3 H, J = 7 Hz)
Example 13 (Scheme 3)
g-N-(Methoxycarbonylmethyl)-ω-N-(4-nitrobenzoyl)-L-lysine ethyl ester (28)
Compound (27) (0.54 g, 1.7 mmoles) was coevaporated with toluene and dissolved in dry acetonitrile (10 ml). Bromoacetic acid methylester (0.265 g, 1.7 mmoles) was added followed by pulverized dry sodium carbonate (2.0 g). The mixture was refluxed for 3 h.
Filtration of the inorganic salts and evaporation of the acetonitrile gave an oily crude product which was purified by flash chromatography.
Yield: 68 %
1H NMR (60 MHz, CDCl3): 8.25 (d, 2 H, J=9 Hz); 7.93 (d, 2 H, J=9 Hz); 6.63 (s, broad, 1 H); 4.13 (q, 2 H, J = 7 Hz); 3.68 (s, 3 H) ; 3.30-3.60 (m, 3 H); 1.40-1.75 (m, 7 H); 1.24 (t, 3 H, J = 7 Hz).
Example 14
GENERAL PROCEDURE FOR THE SYNTHESIS OF REACTIVE LIGAND OR CHELATE EMPLOYING
DERIVATIVES OF α, ω DIAMIN0ACIDS AS STARTING MATERIAL a) The appropriate dihalomethyl bipyridine (1 mmol) in dry acetonitrile (10 ml) is reacted with (1 mmol) of compound (28) in the presence of 2 g powderized
dry sodium carbonate at room temperature with vigorous stirring. After overnight stirring the resulting mixture composed of unreacted dihalomethyl derivative, monohalomethyl diester and symmetrical tetraester is evaporated, coevaporated with toluene and flash chromatographed to obtain pure monohalomethyl diester. b) The monohalomethyl diester (0.2 mmoles) obtained is coevaporated with dry acetonitrile, dissolved in 3 ml of acetonitrile, and 1 g of powderized sodium carbonate is added followed by iminoacetic acid diethyl ester (0.25 mmoles). The mixture is refluxed overnight, filtered and evaporated. The desired functionalized tetraester is obtained after short column chromatography. c) When compound (28) is used as a starting material in Example 14 a) the nitro group has to be reduced to amino prior to ester group hydrolysis and chelate formation. This is performed in the following way:
Solid sodium borohydride (0.3 mmoles) is added to the mixture of the respective product from Example 14 b) followed by 0.2 g palladium on carbon (10%) in 5 ml of dry ethanol. The mixture is stirred at room temperature for 10 min and partitioned between saturated sodium hydrogen carbonate and chloroform. The evaporated organic extracts are flash chromatographed to yield the respective tetraester containing a reactive amino group.
Example 15 (Scheme 1)
4-Ethoxy-6-(N-(methoxycarbonylmethyl)-N-(1-(5-(p-nitrobenzamido))-1-
(ethoxycarbonyl)-pentyl)-aminomethyl)-6'-bromomethyl-2,2'-bipyridine'(6)
This compound was synthesized using the general procedure from Example 14a when
4-ethoxy-6,6'-bis(bromomethyl)-2,2'-bipyridine (5) and modified iminodiacetic acid ester (compound 28) were used as starting materials.
Yield: 38 %
UV (in ethanol): 286 nm, 220 nm
1H NMR (400 MHz, CDC13): 1.30 (t, J=7 Hz); 1.45 (t, J=7 Hz); 1.55-1.68 (m);
1.75-1.83 (m); 3.45 (m); 3.50 (m) ; 3.55 (d, J=15 Hz); 3.64 (s); 3.66 (d, J=15
Hz); 3.94 (d, J=15 Hz); 4.03 (d, J=15 Hz); 4.18 (q, J=7 Hz); 4.19 (q, J=7 Hz);
4.58 ( s) ; 6.83 (s) ; 7 .45 ( s) ; 7 .62 (d, J=7 Hz) ; 7.76 ( t, J=7 Hz) ; 8.00 (d , J=9 Hz) ; 8.25 (d, J=9 Hz) ; 8.28 (d, J=7 Hz) ; 8.35 (s)
A symmetrical disubstituted tetraester (7) was also obtained in 26 % yield.
Example 16 (Scheme 1)
4-Ethoxy-6-(N-(methoxycarbonylmethyl)-N-(1-(5-(p-nitrobenzamido))-1-(ethoxycarbonyl)-pentyl)-aminomethyl-6'-(N,N-bis(ethoxycarbonylmethyl)aminomethyl-
2,2'-bipyridine (8)
This compound was synthesized following the general procedure for tetraester synthesis from Example 14b using compound (6) and diethyl iminodiacetate as starting materials.
Yield: 62 %
UV (in ethanol): 287 nm, 222 nm
1H NMR (400 MHz, CDCI3): 1.26 (t, J=7 Hz); 1.28 (t, J=7 Hz); 1.46 (t, J=7 Hz);
1.59 (m); 1.76 (m) ; 3.35 (m) ; 3.49 (m); 3.58 (d, J=15 Hz); 3.65 (s); 3.66 (s);
3.67 (s); 3.71 (d, J=15 Hz); 3.96 (d, J=15 Hz); 4.05 (d, J=15 Hz); 4.09 (s);
4.14 (q, J=7 Hz); 4.17 (q, J=7 Hz); 6.88 (s); 7.15 (d, J=2 Hz); 7.50 (d, J=7
Hz); 7.75 (d, J=7 Hz); 7.83 (d, J=2 Hz); 8.01 (d, J=9 Hz); 8.24 (d, J=7 Hz);
8.26 (d, J=9 Hz)
Example 17 (Scheme 1)
4-Ethoxy-6-(N-(methoxycarbonylmethyl)-N-(1-(5-(p-aminobenzamido))-1- (ethoxycarbonyl)-pentyl)-aminomethyl)-6'-(N,N-bis(ethoxycarbonylmethyl)aminomethyl)-2,2'-bipyridine (9)
This compound was synthesized using the general procedure for nitrogroup reduction from Example 14c having compound (8) as a starting material.
Yield: 71 %
UV (in ethanol): 286 nm, 222 nm
1H NMR (400 MHz, CDCI3) : 1.26 (t, J=7 Hz); 1.28 (t, J=7 Hz); 1.46 (t, J=7 Hz); 1.60 (m); 1.75 (m); 3.41 (m) ; 3.44 (m); 3.54 (d, J=15 Hz); 3.62 (d, J=15 Hz); 3.64 (s); 3.69 (s); 3.92 (d, J=15 Hz); 4.01 (s); 4.04 (d, J=15 Hz); 4.16 (q, J=7 Hz); 4.17 (q, J=7 Hz); 6.30 (s); 6.64 (d, J=9 Hz); 7.16 (d, J=2 Hz); 7.50 (d, J=7 Hz); 7.63 (d, J=9 Hz); 7.78 (t, J=7 Hz); 7.80 (d, J=2 Hz); 8.24 (d, J=7 Hz)
Example 18 (Scheme 1)
4-Ethoxy-6-(N-(carboxymethyl)-N-(1-(5-(p-aminobenzamido))-1-carboxypentyl)aminomethyl)-6'-(N,N-bis(carboxymethyl)-aminomethyl)-2,2'-bipyridine and its europium (10) and terbium (11) chelates, respectively
Compound (9) (0.25 mmol) dissolved in acetone (10 ml) was treated at 20ºC with sodium hydroxide (1 M, 10 ml) for 1 hour. The alkaline solution was neutralized with concentrated hydrochloric acid and most of the salts were precipitated by addition of acetone (20 ml). The salts were filtered off and the organic solvent was evaporated. The residual aqueous solution of tetra acid was adjusted to pH 5.0 and divided into two equal portions. To each was added an equivalent amount of EuCl3 or TbCl3 respectively in the form of a solution in water (5 ml) and both mixtures were stirred at this pH for 30 min whereupon the pH's were increased to 8.0. Some precipitates were formed in both reactions and were filtered off. Most of the water was evaporated under reduced pressure and both the europium (10) and the terbium (11) chelate were isolated as the solids material after precipitation from acetone (50 ml).
Example 19 (Scheme 1)
isothiocyano chelates
To the amino chelate (10) or (11) (100 mg) dissolved separately in 5 ml of water and vigorously stirred, thiophosgene (80 μl) dissolved in chloroform (3 ml) was added at once and the mixtures were stirred at RT for 1 h.
The water phases were separated, extracted with chloroform (3 x 3 ml) and concentrated to a volume of 0.5 ml. Addition of ethanol (10 ml) precipitated isothiocyano functionalized europium chelate (12) and terbium chelate (13) quantitatively as white solids. The TLC (Acetonitrile/H2O 4:1) and fluorescence developing with acetonylacetone /EtOH (1:20) showed only a single product which was negative to a fluorescamine test for free amines.
Example 20 (Scheme 2)
6-Bromomethyl-6'-(N,N-bis(ethoxycarbonylmethyl)aminomethyl)-2,2'dipyridyl ketone (19)
The monobromomethyl diester (19) was synthesized starting from compound (18) and one molecular equivalent of iminodiacetic acid diethyl ester, in a reaction analogous to that of Example 14 a. Yield: 62 %. 1H NMR (60 MHz, CDCl3) : 1.21 (t, 6 H), 3.60 (s, 4 H), 4.08 (s, 2 H), 4.15 (q, 4 H), 4.58 (s, 2 H), 7.22-8.15 (m, 6 H) .
In the same reaction the symmetrical tetraester (20) was obtained and isolated with a 21 % yield.
Example 21 ( Scheme 2)
6-(N-(methoxycarbonylmethyl)-N-( 1-(5-(p-aminobenzamido)-l-(ethoxycarbonyl)- pentyl)aminomethyl-6'-(N,N-bis(ethoxycarbonylmethyl)aminomethyl)-2,2'dipyridyl ketone (21) a) The nitro group in compound (28) (2.1 g, 5 mmol): 20 ml of dry methanol was reduced with sodium borohydride (10 mmol) in the presence of palladium on carbon (10 %, 0.2 g). The reaction mixture was stirred at RT for 15 min and partitioned between saturated sodium hydrogen carbonate and chloroform. The evaporated organic phase was flash chromatographed to yield the oily product (29 in scheme 3) pure by TLC and NMR. Yield 84 %. 1H NMR (400 MHz, CDCl3); 1.25 (t, 3 H), 1.45 - 1.80 (m, 6 H) 3.39 - 3.48
(m, 3 H), 3.57 (s, 2 H), 3.70 (s, 3 H), 4.17 (q, 2 H), 6.28 (t, 1 H, broad),
6.64 (d, 2 H, J = 8.7 Hz), 7.63 (d, 2 H, J = 8.7 Hz). b) compound (19) was reacted with the above reduced derivative of (28) (2 eq) under the conditions described in Example 14 b.
Filtration, evaporation of solvent and flash chromatography gave the product free from minor contaminations of isomeric tetraester which resulted from coupling via aromatic amino group. Yield 79 %. 1H NMR (400 MHz, CDC13) : 1.20 - 1.30 (m, 9 H), 1.45 - 1.80 (m, 6 H) , 3.50 - 3.67 (d.d., 2 H, J = 17.7 Hz), 3.64 (s, 4 H), 3.70 (s, 3 H) , 4.01 (s, 2 H), 3.89-4.05 (d.d., 2 H), 4.12 - 4.20 (m, 6 H), 6.28 (t, 1 H, broad), 6.64 (d, 2 H, J = 8.7 Hz), 7.20 - 7.80 (m, 6 H) , 7.63 (d, 2 H, J = 8.7 Hz)
Example 22 (Scheme 2)
6-(N-(carboxymethyl)-N-(1-(5-(p-aminobenzamido)-1-carboxypentyl)aminomethyl-6'- (N,N-bis(carboxymethyl)aminomethyl)-2,2'dipyridyl ketone, its europium (22) and terbium chelates (23) and their isothiocyano derivatives (24) and (25)
Hydrolysis of compound (21), formation of europium (22) and terbium (23) chelates and their reactions with thiophosgene to form the isothiocyano
derivatives (24) and (25), respectively, were performed as described in Examples 18 and 19. Both final products were stored in the form of ethanol precipitates.
Example 23
M 13 phage sequencing primer and its labeling with lanthanide chelates
The hexadecamer oligonucleotide of M 13 phage sequencing primer was synthesized using Pharmacia Gen Assembler solid phase nucleic acid synthesizer (Pharmacia, Sweden) following the recommended conditions. When the oligonucleotide synthesis had been accomplished the detritylated compound was subjected to the reaction with 1,1'-carbonyldiimidazole and diaminohexane according to Nucleic Acids Research 14,, 7987-7994 (1986).
The deprotection of such a synthesized primer was made under standard conditions and was followed by preparative FPLC. The isolated 5'-amino modified hexadecamer was pure as shown by chromatographic and electrophoretic analysis.
Four portions of the above oligonucleotide (5 OD each) were reacted at RT for 6 h with lanthanide chelates 12, 13, 24 and 25, (3 mg) respectively, each reaction being carried out in a solution containing sodium carbonate (0.2 M, 1.0 ml).
The reactions were monitored by FPLC, and labeled products from each reaction were separated in ion-pair mode using the reverse phase FPLC system. The purified sequences were characterized by their fluorescent spectra which were found to be identical to the unbound labels.
Moreover, the four differently labeled primers did not show any differences in their electrophoretic mobilities when run under the real sequencing conditions on a 20 % acrylamide gel. This reflects the fact that all labels employed are indeed very closely structure related. No differences were found even when electrophoresis was used for running free labels.
It should be noted also that despite the rather high gel temperature (50ºC), and despite the presence of additional complexing agents (EDTA) in the electrophoretical buffer, there was no sign of instability of any of the lanthanide chelates.
Example 24
Sequencing reactions
To prove the applicability of the invented markers as a tag for nucleic acids sequencing, all differently labeled oligonucleotides were used as sequencing primers in the sequence analysis performed by standard methods (Proc Natl. Acad. Sci. USA 74, 5463-5467), utilizing α-32P dCTP as a radiolabel. In each case only one dideoxynucleotide (ddATP) was used and the resulting mixtures were run parallelly on the sequencing gel.
All primers gave the same sequencing pattern indicating that the derivatized primers retain their ability to hybridize specifically to the complementary strand.
No evidence was found that the bands obtained differ in their mobilities.
The appropriate bands were cut out and the presence of europium was found using Arcus Fluorometer (Wallac Oy, Finland) and enhancement solution (Wallac Oy).
Claims
Claim
Method for simultaneous real time fluorometric sequence analysis of nucleic acid fragments of different lengths and four different terminals, the fragments being labeled with different fluorescent labels for the respective terminating bases, said method comprising
- electrophoretically separating the mixture of the four labeled fragments along a single path in a separation medium,
- focusing fluorometric excitation light on a predetermined spot in said medium through which spot the fragments move,
- detecting photons emitted by the respective labels upon excitation by said light when the fragments move through said spot, and
- determining the nucleic acid sequence on the basis of the photons emitted by the different labels, characterized in that the fragments are labelled with four different labels comprising the same two lanthanides and the same two ligands as follows: label 1 = ligand 1 + lanthanide 1
label 2 = ligand 2 + lanthanide 1
label 3 = ligand 1 + lanthanide 2
label 4 = ligand 2 + lanthanide 2 where ligands 1 and 2 have different excitation wavelengths and lanthanides 1 and 2 have different emission wavelengths, that the excitation light is generated in the form of light pulses alternating between the different excitation wavelengths of the ligands, and that the photons emitted by the labels are detected periodically for the different emission wavelengths of the lanthanides.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8802573A SE8802573D0 (en) | 1988-07-08 | 1988-07-08 | MULTI-LABEL TIME-RESOLVED FLUORESCENCE ANALYSIS OF NUCLEIC ACID SEQUENCES USING LANTHANIDE CHELATES |
| SE8802573-9 | 1988-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1990000623A1 true WO1990000623A1 (en) | 1990-01-25 |
Family
ID=20372870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/SE1989/000378 WO1990000623A1 (en) | 1988-07-08 | 1989-07-03 | Multi-label time-resolved fluorescence analysis of nucleic acid sequences using lanthanide chelates |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0386180A1 (en) |
| JP (1) | JPH03500249A (en) |
| SE (1) | SE8802573D0 (en) |
| WO (1) | WO1990000623A1 (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0340675A3 (en) * | 1988-05-02 | 1991-08-14 | The Perkin-Elmer Corporation | Time-resolved fluorimetric detection of lanthanide labeled nucleotides |
| WO1992014841A1 (en) * | 1991-02-14 | 1992-09-03 | Baxter Diagnostics Inc. | Novel lanthanide chelate-conjugated oligonucleotides |
| FR2687687A1 (en) * | 1992-02-25 | 1993-08-27 | Us Energy | METHOD FOR MEASURING THE SIZE OF DNA FRAGMENTS |
| EP0516753A4 (en) * | 1990-02-26 | 1994-05-18 | Us Health | A method for the fluorescent detection of a dna sequence in real time |
| WO2000039335A1 (en) * | 1998-12-24 | 2000-07-06 | Aclara Biosciences, Inc. | Individually addressable solid surfaces for multiplexed operations |
| US6329205B1 (en) | 1999-08-31 | 2001-12-11 | Molecular Probes, Inc. | Detection method using luminescent europium-based protein stains |
| EP1104491A4 (en) * | 1998-08-11 | 2003-01-29 | Caliper Techn Corp | Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
| US6716394B2 (en) | 1998-08-11 | 2004-04-06 | Caliper Technologies Corp. | DNA sequencing using multiple fluorescent labels being distinguishable by their decay times |
| WO2007104834A1 (en) * | 2006-03-13 | 2007-09-20 | Wallac Oy | Terminating substrates for dna polymerases |
| US7482444B2 (en) | 2006-03-13 | 2009-01-27 | Wallac Oy | Terminating substrates for DNA polymerases |
| US9062342B2 (en) | 2012-03-16 | 2015-06-23 | Stat-Diagnostica & Innovation, S.L. | Test cartridge with integrated transfer module |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1504599A (en) * | 1997-12-17 | 1999-07-05 | Shionogi & Co., Ltd. | Novel pyridine compounds |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3501306A1 (en) * | 1984-01-16 | 1985-07-25 | California Institute Of Technology, Pasadena, Calif. | METHOD FOR ELECTROPHORETIC ANALYSIS OF DNA FRAGMENTS |
| EP0252683A2 (en) * | 1986-07-02 | 1988-01-13 | E.I. Du Pont De Nemours And Company | Process and reagents for DNA sequence analysis |
| EP0268406A2 (en) * | 1986-11-06 | 1988-05-25 | AMERSHAM INTERNATIONAL plc | Apparatus for biochemical sequencing |
-
1988
- 1988-07-08 SE SE8802573A patent/SE8802573D0/en unknown
-
1989
- 1989-07-03 WO PCT/SE1989/000378 patent/WO1990000623A1/en not_active Application Discontinuation
- 1989-07-03 EP EP89907852A patent/EP0386180A1/en not_active Withdrawn
- 1989-07-03 JP JP1507291A patent/JPH03500249A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3501306A1 (en) * | 1984-01-16 | 1985-07-25 | California Institute Of Technology, Pasadena, Calif. | METHOD FOR ELECTROPHORETIC ANALYSIS OF DNA FRAGMENTS |
| EP0252683A2 (en) * | 1986-07-02 | 1988-01-13 | E.I. Du Pont De Nemours And Company | Process and reagents for DNA sequence analysis |
| EP0268406A2 (en) * | 1986-11-06 | 1988-05-25 | AMERSHAM INTERNATIONAL plc | Apparatus for biochemical sequencing |
Non-Patent Citations (2)
| Title |
|---|
| Nature, Vol 321, 12 June 1986, LLOYD M. SMITH et al: "Fluorescence Detection in Automated DNA Sequence Analysis", p 674-679 see Abstract, figures 1-3 * |
| Nucleic Acids Research, Vol 15, No 11, 1987, WILHELM ANSORGE et al: "Automated DNA Sequencing: Ultrasensitive Detection of Fluorescent Bands during Electrophoresis", p 4593-4601 see Abstract, p 4600 line 23 - p 4601 line 21 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0340675A3 (en) * | 1988-05-02 | 1991-08-14 | The Perkin-Elmer Corporation | Time-resolved fluorimetric detection of lanthanide labeled nucleotides |
| EP0516753A4 (en) * | 1990-02-26 | 1994-05-18 | Us Health | A method for the fluorescent detection of a dna sequence in real time |
| WO1992014841A1 (en) * | 1991-02-14 | 1992-09-03 | Baxter Diagnostics Inc. | Novel lanthanide chelate-conjugated oligonucleotides |
| US5955601A (en) * | 1991-02-14 | 1999-09-21 | E G & G Wallac | Lanthanide chelate conjugated oligonucleotides |
| FR2687687A1 (en) * | 1992-02-25 | 1993-08-27 | Us Energy | METHOD FOR MEASURING THE SIZE OF DNA FRAGMENTS |
| US6716394B2 (en) | 1998-08-11 | 2004-04-06 | Caliper Technologies Corp. | DNA sequencing using multiple fluorescent labels being distinguishable by their decay times |
| EP1104491A4 (en) * | 1998-08-11 | 2003-01-29 | Caliper Techn Corp | Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
| WO2000039335A1 (en) * | 1998-12-24 | 2000-07-06 | Aclara Biosciences, Inc. | Individually addressable solid surfaces for multiplexed operations |
| US6329205B1 (en) | 1999-08-31 | 2001-12-11 | Molecular Probes, Inc. | Detection method using luminescent europium-based protein stains |
| WO2007104834A1 (en) * | 2006-03-13 | 2007-09-20 | Wallac Oy | Terminating substrates for dna polymerases |
| GB2450454A (en) * | 2006-03-13 | 2008-12-24 | Wallac Oy | Terminating substrates for DNA polymerases |
| US7482444B2 (en) | 2006-03-13 | 2009-01-27 | Wallac Oy | Terminating substrates for DNA polymerases |
| GB2450454B (en) * | 2006-03-13 | 2011-04-13 | Wallac Oy | Terminating substrates for DNA polymerases |
| US9062342B2 (en) | 2012-03-16 | 2015-06-23 | Stat-Diagnostica & Innovation, S.L. | Test cartridge with integrated transfer module |
| US9334528B2 (en) | 2012-03-16 | 2016-05-10 | Stat-Diagnostica & Innovation, S.L. | Test cartridge with integrated transfer module |
| US9757725B2 (en) | 2012-03-16 | 2017-09-12 | Stat-Diagnostica & Innovation, S.L. | Test cartridge with integrated transfer module |
| US9914119B2 (en) | 2012-03-16 | 2018-03-13 | Stat-Diagnostica & Innovation, S.L. | Test cartridge with integrated transfer module |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03500249A (en) | 1991-01-24 |
| EP0386180A1 (en) | 1990-09-12 |
| SE8802573D0 (en) | 1988-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2781378B2 (en) | Reporter-labeled chain terminator | |
| US5306403A (en) | Raman-based system for DNA sequencing-mapping and other separations | |
| US6447724B1 (en) | DNA sequencing using multiple fluorescent labels being distinguishable by their decay times | |
| US5591581A (en) | Electrochemiluminescent rhenium moieties and methods for their use | |
| US5800999A (en) | Dioxetane-precursor-labeled probes and detection assays employing the same | |
| US8436153B2 (en) | Cyanine dyes | |
| US5854008A (en) | Europium and terbium chelators for the time-resolved fluorometric assays | |
| EP0599338A2 (en) | Method for detecting target nucleic acid | |
| WO1990000623A1 (en) | Multi-label time-resolved fluorescence analysis of nucleic acid sequences using lanthanide chelates | |
| US7314711B2 (en) | Assays employing electrochemiluminescent labels and electrochemiluminescence quenchers | |
| JPS62500663A (en) | Luminescent metal chelate label and detection means | |
| JPH0743347B2 (en) | Method and apparatus for determining DNA base sequence | |
| JPH02174792A (en) | Experimental agent to prepare 5'-added oligonucleotide | |
| JPH10502702A (en) | Power generation chemiluminescent labels for analysis and / or referencing | |
| CN106967078A (en) | A kind of lysosome targeting hypochlorous acid fluorescence probe and its preparation and application | |
| WO2023093399A1 (en) | Benzothiazole-parent-based fluorescent probe for detection of palladium ions, and preparation method therefor and use thereof | |
| Fuchigami et al. | Subattomole detection of amino acids by capillary electrophoresis based on semiconductor laser fluorescence detection | |
| McMahon et al. | Lanthanide luminescence sensing of copper and mercury ions using an iminodiacetate-based Tb (III)-cyclen chemosensor | |
| JP6958781B2 (en) | Fluorescent compound or salt thereof, ionic compound detection agent and ionic compound detection method | |
| US3871825A (en) | Fluorometric reagents and methods | |
| Kim et al. | Synthesis and characterization of electrochemiluminescent ruthenium (II) complexes containing o-phenanthroline and various α-diimine ligands | |
| Piyanuch et al. | Development of a new series of thioacetal based fluorescence chemosensors for highly sensitive determination of Hg2+ in environmental samples and cell imaging | |
| Kwiatkowski et al. | Solid-phase synthesis of chelate-labelled oligonucleotides: application in triple-color ligase-mediated gene analysis | |
| CN101200447B (en) | Bifunctional chemical, preparation and use for detecting nucleic acid, system comprising the compound | |
| CN108558859A (en) | A kind of preparation and application of the long wave mode Hg2+ fluorescence probes of visualization based on chromene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1989907852 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1989907852 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1989907852 Country of ref document: EP |